Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Multidisciplinary Management of Breast Cancer During Pregnancy.

Shachar SS, Gallagher K, McGuire K, Zagar TM, Faso A, Muss HB, Sweeting R, Anders CK.

Oncologist. 2017 Mar;22(3):324-334. doi: 10.1634/theoncologist.2016-0208. Epub 2017 Feb 23. Review.

PMID:
28232597
2.

The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer.

Ordu C, McGuire K, Alco G, Nur Pilanci K, Koksal UI, Elbüken F, Erdogan Z, Agacayak F, Ilgun S, Sarsenov D, Öztürk A, İğdem Ş, Okkan S, Eralp Y, Dincer M, Ozmen V.

Cureus. 2016 Jun 7;8(6):e633. doi: 10.7759/cureus.633.

3.

Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes.

Ashkani J, Naidoo KJ.

Sci Rep. 2016 May 20;6:26451. doi: 10.1038/srep26451.

4.

A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.

Bastos EP, Brentani H, Pereira CA, Polpo A, Lima L, Puga RD, Pasini FS, Osorio CA, Roela RA, Achatz MI, Trapé AP, Gonzalez-Angulo AM, Brentani MM.

PLoS One. 2016 May 6;11(5):e0154325. doi: 10.1371/journal.pone.0154325. eCollection 2016.

5.

Molecular biology of breast tumors and prognosis.

Baldassarre G, Belletti B.

F1000Res. 2016 Apr 21;5. pii: F1000 Faculty Rev-711. doi: 10.12688/f1000research.8158.1. eCollection 2016. Review.

6.

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice.

Gallagher CM, More K, Masaquel A, Kamath T, Guerin A, Ionescu-Ittu R, Nitulescu R, Gauthier-Loiselle M, Sicignano N, Butts E, Wu EQ, Barnett B.

Springerplus. 2016 Mar 31;5:395. doi: 10.1186/s40064-016-2008-9. eCollection 2016.

7.

Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort.

D'Aiuto M, Chirico A, De Riggi MA, Frasci G, De Laurentiis M, Di Bonito M, Vici P, Pizzuti L, Sergi D, Maugeri-Saccà M, Barba M, Giordano A.

Cancer Biol Ther. 2016 May 3;17(5):470-6. doi: 10.1080/15384047.2016.1156265. Epub 2016 Mar 2.

8.

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade OI, Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport-Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ, Hallberg E, Ruddy KJ, Sharma P, Kim SW; kConFab Investigators, Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Pujana MA, Balmaña J, Diez O, Ivady G, Papp J, Olah E, Kwong A; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Nevanlinna H, Aittomäki K, Perez Segura P, Caldes T, Van Maerken T, Poppe B, Claes KB, Isaacs C, Elan C, Lasset C, Stoppa-Lyonnet D, Barjhoux L, Belotti M, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Hahnen E, Kast K, Arnold N, Varon-Mateeva R, Wand D, Godwin AK, Evans DG, Frost D, Perkins J, Adlard J, Izatt L, Platte R, Eeles R, Ellis S; EMBRACE, Hamann U, Garber J, Fostira F, Fountzilas G, Pasini B, Giannini G, Rizzolo P, Russo A, Cortesi L, Papi L, Varesco L, Palli D, Zanna I, Savarese A, Radice P, Manoukian S, Peissel B, Barile M, Bonanni B, Viel A, Pensotti V, Tommasi S, Peterlongo P, Weitzel JN, Osorio A, Benitez J, McGuffog L, Healey S, Gerdes AM, Ejlertsen B, Hansen TV, Steele L, Ding YC, Tung N, Janavicius R, Goldgar DE, Buys SS, Daly MB, Bane A, Terry MB, John EM, Southey M, Easton DF, Chenevix-Trench G, Antoniou AC, Ottini L.

Breast Cancer Res. 2016 Feb 9;18(1):15. doi: 10.1186/s13058-016-0671-y.

9.

Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.

Tricoli JV, Blair DG, Anders CK, Bleyer WA, Boardman LA, Khan J, Kummar S, Hayes-Lattin B, Hunger SP, Merchant M, Seibel NL, Thurin M, Willman CL.

Cancer. 2016 Apr 1;122(7):1017-28. doi: 10.1002/cncr.29871. Epub 2016 Feb 5. Review.

10.

Genomic aberrations in young and elderly  breast cancer patients.

Azim HA Jr, Nguyen B, Brohée S, Zoppoli G, Sotiriou C.

BMC Med. 2015 Oct 15;13:266. doi: 10.1186/s12916-015-0504-3.

11.

Prognostic effect analysis of molecular subtype on young breast cancer patients.

Chen HL, Ding A, Wang FW.

Chin J Cancer Res. 2015 Aug;27(4):428-36. doi: 10.3978/j.issn.1000-9604.2015.08.02.

12.

The molecular landscape of premenopausal breast cancer.

Liao S, Hartmaier RJ, McGuire KP, Puhalla SL, Luthra S, Chandran UR, Ma T, Bhargava R, Modugno F, Davidson NE, Benz S, Lee AV, Tseng GC, Oesterreich S.

Breast Cancer Res. 2015 Aug 7;17:104. doi: 10.1186/s13058-015-0618-8.

13.

IVF for fertility preservation in breast cancer patients--efficacy and safety issues.

Shapira M, Raanani H, Meirow D.

J Assist Reprod Genet. 2015 Aug;32(8):1171-8. doi: 10.1007/s10815-015-0519-x. Epub 2015 Jul 1. Review.

14.

Gene expression in "young adult type" breast cancer: a retrospective analysis.

Johnson RH, Hu P, Fan C, Anders CK.

Oncotarget. 2015 May 30;6(15):13688-702.

15.

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.

Lehmann BD, Ding Y, Viox DJ, Jiang M, Zheng Y, Liao W, Chen X, Xiang W, Yi Y.

BMC Cancer. 2015 Mar 26;15:179. doi: 10.1186/s12885-015-1102-7.

16.

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.

Huang X, Dugo M, Callari M, Sandri M, De Cecco L, Valeri B, Carcangiu ML, Xue J, Bi R, Veneroni S, Daidone MG, Ménard S, Tagliabue E, Shao Z, Wu J, Orlandi R.

Cancer Med. 2015 Jul;4(7):1016-30. doi: 10.1002/cam4.442. Epub 2015 Mar 18.

17.

Unique features of young age breast cancer and its management.

Lee HB, Han W.

J Breast Cancer. 2014 Dec;17(4):301-7. doi: 10.4048/jbc.2014.17.4.301. Epub 2014 Dec 26. Review.

18.

Biology of breast cancer in young women.

Azim HA Jr, Partridge AH.

Breast Cancer Res. 2014 Aug 27;16(4):427. doi: 10.1186/s13058-014-0427-5. Review.

19.

Breast cancer in young women: special considerations in multidisciplinary care.

Reyna C, Lee MC.

J Multidiscip Healthc. 2014 Sep 29;7:419-29. doi: 10.2147/JMDH.S49994. eCollection 2014. Review.

20.

Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.

Riedl CC, Slobod E, Jochelson M, Morrow M, Goldman DA, Gonen M, Weber WA, Ulaner GA.

J Nucl Med. 2014 Oct;55(10):1578-83. doi: 10.2967/jnumed.114.143297. Epub 2014 Sep 11.

Supplemental Content

Support Center